This time of year finds many of us busy with holiday shopping. While PNNL might not be developing the latest video games or hoverboards, we are working hard to deliver a few presents you might like.
Fifteen PNNL scientists are part of a team that has identified a set of biomarkers that indicate which patients infected with the Ebola virus are most at risk of dying from the disease.
PNNL scientists are part of a nationwide effort to learn more about the role of proteins in cancer biology and to use that information to benefit cancer patients.
PNNL scientists have gotten one of the most in-depth looks ever at the developing lung, characterizing hundreds of lipids and thousands of proteins from samples as small as just 4,000 cells.